Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma
Markus Raderer, Stefan Wöhrer, Rupert Bartsch, et al.
Pathology
|
September 22, 2010
Primary central nervous system lymphoma: a clinicopathological study of 75 cases
Matthias Preusser, Adelheid Woehrer, Oskar Koperek, et al.
Cancers
|
April 23, 2022
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
Lorenz Schubert, Maximilian Koblischke, Lisa Schneider, et al.
Hemasphere
|
April 21, 2021
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Renaud Heine, Frederick W Thielen, Marc Koopmanschap, et al.
European Journal of Clinical Investigation
|
May 18, 2012
Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma
Johanna Atamaniuk, Andreas Gleiss, Edit Porpaczy, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 11, 2003
Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16)
Birgit Kainz, Daniel Heintel, Rodrig Marculescu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2016
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)
Michael A Fridrik, Ulrich Jaeger, Andreas Petzer, et al.
Investigative Radiology
|
April 12, 2018
[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results
Marius E Mayerhoefer, Ulrich Jaeger, Philipp Staber, et al.
Blood Advances
|
March 17, 2020
Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program
Georg Gelbenegger, Christian Schoergenhofer, Ulla Derhaschnig, et al.
Leukemia & Lymphoma
|
February 23, 2011
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study
Corinne Haioun, Antonio Salar, Ruth Pettengell, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma
Markus Raderer, Stefan Wöhrer, Rupert Bartsch, et al.
Pathology
|
September 22, 2010
Primary central nervous system lymphoma: a clinicopathological study of 75 cases
Matthias Preusser, Adelheid Woehrer, Oskar Koperek, et al.
Cancers
|
April 23, 2022
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
Lorenz Schubert, Maximilian Koblischke, Lisa Schneider, et al.
Hemasphere
|
April 21, 2021
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Renaud Heine, Frederick W Thielen, Marc Koopmanschap, et al.
European Journal of Clinical Investigation
|
May 18, 2012
Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma
Johanna Atamaniuk, Andreas Gleiss, Edit Porpaczy, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
January 11, 2003
Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16)
Birgit Kainz, Daniel Heintel, Rodrig Marculescu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2016
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)
Michael A Fridrik, Ulrich Jaeger, Andreas Petzer, et al.
Investigative Radiology
|
April 12, 2018
[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results
Marius E Mayerhoefer, Ulrich Jaeger, Philipp Staber, et al.
Blood Advances
|
March 17, 2020
Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program
Georg Gelbenegger, Christian Schoergenhofer, Ulla Derhaschnig, et al.
Leukemia & Lymphoma
|
February 23, 2011
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study
Corinne Haioun, Antonio Salar, Ruth Pettengell, et al.
Page
of 11